253 related articles for article (PubMed ID: 26080826)
1. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
Hu Y; Tao L; Lyu B
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
Niu HL; Xiao JY
Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.
Moayyedi P; Ford AC; Talley NJ; Cremonini F; Foxx-Orenstein AE; Brandt LJ; Quigley EM
Gut; 2010 Mar; 59(3):325-32. PubMed ID: 19091823
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.
Wen Y; Li J; Long Q; Yue CC; He B; Tang XG
Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213
[TBL] [Abstract][Full Text] [Related]
8. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
[TBL] [Abstract][Full Text] [Related]
9. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X
Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.
Zheng H; Chen R; Zhao X; Li G; Liang Y; Zhang H; Chi Z
Pain Res Manag; 2019; 2019():2871505. PubMed ID: 31814859
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
Xu HL; Zou LL; Chen MB; Wang H; Shen WM; Zheng QH; Cui WY
PLoS One; 2021; 16(8):e0255160. PubMed ID: 34358238
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Yang R; Jiang J; Ouyang J; Zhao Y; Xi B
Clin Nutr ESPEN; 2024 Apr; 60():362-372. PubMed ID: 38479936
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ
Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
[TBL] [Abstract][Full Text] [Related]
14. Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis.
Wang W; Wang F; Fan F; Sedas AC; Wang J
Int J Behav Med; 2017 Apr; 24(2):191-204. PubMed ID: 27646279
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
McFarland LV; Dublin S
World J Gastroenterol; 2008 May; 14(17):2650-61. PubMed ID: 18461650
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis.
Zhang FM; Li S; Ding L; Xiang SH; Zhu HT; Yu JH; Xu GQ
Medicine (Baltimore); 2019 Jul; 98(28):e16297. PubMed ID: 31305414
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis.
Chen M; Yuan L; Xie CR; Wang XY; Feng SJ; Xiao XY; Zheng H
Int J Surg; 2023 Nov; 109(11):3631-3647. PubMed ID: 37565634
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome.
Hoveyda N; Heneghan C; Mahtani KR; Perera R; Roberts N; Glasziou P
BMC Gastroenterol; 2009 Feb; 9():15. PubMed ID: 19220890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
